Milestone Drug Patent Portfolio

Milestone owns 1 orange book drug protected by 6 US patents Given below is the list of Milestone's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US12257224 Methods Of Administration For Highly Water-Soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker 15 Jul, 2042
Active
US10117848 Highly Water-Soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker And Uses Thereof 13 Apr, 2036
Active
US10010522 Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof 19 Jun, 2028
Active
US10010523 Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof 19 Jun, 2028
Active
US9227918 Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof 19 Jun, 2028
Active
US9463179 Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof 19 Jun, 2028
Active


Milestone's Family Patents


Family Patents



Milestone Drug List

Given below is the complete list of Milestone's drugs and the patents protecting them.


1. Cardamyst

Cardamyst is protected by 6 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US12257224 Methods Of Administration For Highly Water-Soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker 15 Jul, 2042
(16 years from now)
Active
US10117848 Highly Water-Soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker And Uses Thereof 13 Apr, 2036
(10 years from now)
Active
US10010522 Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof 19 Jun, 2028
(2 years from now)
Active
US10010523 Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof 19 Jun, 2028
(2 years from now)
Active
US9227918 Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof 19 Jun, 2028
(2 years from now)
Active
US9463179 Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof 19 Jun, 2028
(2 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cardamyst's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List